Indication

Boutonneuse fever

Boutonneuse fever, also known as Mediterranean spotted fever, is a zoonotic tick-borne infection caused by the obligate intracellular bacterium *Rickettsia conorii* and transmitted primarily by the brown dog tick (*Rhipicephalus sanguineus*). Read more about Boutonneuse fever

151 drugs 90 manufacturers

Advertisement

Drugs that treat it

Common Boutonneuse fever therapies.

Showing 19–27 of 151 drugs

Filter & compare in the drug finder →Opens the drug finder with Boutonneuse fever preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Boutonneuse fever.

Boutonneuse fever, also known as Mediterranean spotted fever, is a zoonotic tick-borne infection caused by the obligate intracellular bacterium *Rickettsia conorii* and transmitted primarily by the brown dog tick (*Rhipicephalus sanguineus*).

Pathophysiologically, the organism invades and proliferates within vascular endothelial cells, causing systemic microvascular injury and widespread perivascular inflammation.

Clinically, it affects individuals exposed in endemic regions—such as the Mediterranean basin, parts of Africa, and the Indian subcontinent—and typically presents with an abrupt onset of high fever, flu-like symptoms, a characteristic necrotic inoculation eschar known as a "tache noire" at the tick bite site, and a centripetally spreading maculopapular rash that often involves the palms and soles.

Personalize your experience

Follow Boutonneuse fever and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it